Task-induced brain activity patterns in type 2 diabetes: A potential biomarker for cognitive decline

Diabetes

Volumn 63, Issue 9, 2014, Pages 3112-3119

  Marder, Thomas J ^a   Flores, Veronica L ^a,b   Bolo, Nicolas R ^c,d   Hoogenboom, Wouter S ^a,e,f   Simonson, Donald C ^d,g   Jacobson, Alan M ^a,d,h   Foote, Sarah E ^a,i   Shenton, Martha E ^d,e,j   Sperling, Reisa A ^d,k   Musen, Gail ^a,d  

^a JOSLIN DIABETES CENTER   (United States)

^b BRANDEIS UNIVERSITY   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^g Division of Endocrinology Diabetes and Hypertension   (United States)

^h WINTHROP UNIVERSITY HOSPITAL   (United States)

ⁱ TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j Laboratory of Neuroscience   (United States)

^k MASSACHUSETTS GENERAL HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; BRAIN; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREFRONTAL CORTEX; PRIORITY JOURNAL; RECOGNITION; TASK PERFORMANCE;

BIOLOGICAL MARKERS; BRAIN; BRAIN MAPPING; COGNITION DISORDERS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 84906674637     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-1783     Document Type: Article

References (25)

1. Whitmer RA, Gustafson DR, Barrett-Connor E, Haan MN, Gunderson EP, Yaffe K. Central obesity and increased risk of dementia more than three decades later. Neurology 2008;71:1057-1064.
2. Reijmer YD, van den Berg E, Ruis C, Kappelle LJ, Biessels GJ. Cognitive dysfunction in patients with type 2 diabetes. Diabetes Metab Res Rev 2010;26: 507-519.
3. Shaffer JL, Petrella JR, Sheldon FC, et al.; Alzheimer's Disease Neuroimaging Initiative. Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers. Radiology 2013;266:583-591.
4. Jack CR Jr, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 2010;9:119-128.
5. Greicius MD, Srivastava G, Reiss AL, Menon V. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci USA 2004;101:4637-4642.
6. Celone KA, Calhoun VD, Dickerson BC, et al. Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis. J Neurosci 2006;26:10222-10231.
7. Perantie DC, Wu J, Koller JM, et al. Regional brain volume differences associated with hyperglycemia and severe hypoglycemia in youth with type 1 diabetes. Diabetes Care 2007;30:2331-2337.
8. Musen G, Jacobson AM, Bolo NR, et al. Resting-state brain functional connectivity is altered in type 2 diabetes. Diabetes 2012;61:2375-2379.
9. Baker LD, Cross DJ, Minoshima S, Belongia D, Watson GS, Craft S. Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Arch Neurol 2011;68:51-57.
10. Schott BH, Wüstenberg T, Wimber M, et al. The relationship between level of processing and hippocampal-cortical functional connectivity during episodic memory formation in humans. Hum Brain Mapp 2013;34:407-424.
11. Buckner RL, Petersen SE, Ojemann JG, Miezin FM, Squire LR, Raichle ME. Functional anatomical studies of explicit and implicit memory retrieval tasks. J Neurosci 1995;15:12-29.
12. van Harten B, Oosterman JM, Potter van Loon BJ, Scheltens P, Weinstein HC. Brain lesions on MRI in elderly patients with type 2 diabetes mellitus. Eur Neurol 2007;57:70-74.
13. Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971;9:97-113.
14. Yonelinas AP, Hopfinger JB, Buonocore MH, Kroll NE, Baynes K. Hippocampal, parahippocampal and occipital-temporal contributions to associative and item recognition memory: an fMRI study. Neuroreport 2001;12:359-363.
15. Liu CC, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 2013;9:106-118.
16. Duff K, Foster NL, Dennett K, et al. Amyloid deposition and cognition in older adults: the effects of premorbid intellect. Arch Clin Neuropsychol 2013;28:665-671.
17. Musen G, Lyoo IK, Sparks CR, et al. Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes 2006;55: 326-333.
18. de la Monte SM, Wands JR. Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease. J Alzheimers Dis 2005;7:45-61.
19. Crane PK, Walker R, Hubbard RA, et al. Glucose levels and risk of dementia. N Engl J Med 2013;369:540-548.
20. Thambisetty M, Jeffrey Metter E, Yang A, et al. Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging. JAMA Neurol 2013;70:1167-1172.
21. Fliessbach K, Trautner P, Quesada CM, Elger CE, Weber B. Cerebellar contributions to episodic memory encoding as revealed by fMRI. Neuroimage 2007;35:1330-1337.
22. Filippini N, Ebmeier KP, MacIntosh BJ, et al. Differential effects of the apoE genotype on brain function across the lifespan. Neuroimage 2011;54:602-610.
23. Persson J, Lind J, Larsson A, et al. Altered deactivation in individuals with genetic risk for Alzheimer's disease. Neuropsychologia 2008;46:1679-1687.
24. Seaquist ER, Chen W, Benedict LE, et al. Insulin reduces the BOLD response but is without effect on the VEP during presentation of a visual task in humans. J Cereb Blood Flow Metab 2007;27:154-160.
25. Friston KJ. Testing for anatomically specified regional effects. Hum Brain Mapp 1997;5:133-136.